Company profile for Abiomed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Abiomed (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded ...
Abiomed (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22 Cherry Hill Drive Danvers, Massachusetts 01923
Telephone
Telephone
978.646.1400
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/medtech/former-abiomed-ceo-launches-bid-governor-massachusetts

FIERCE BIOTECH
01 Oct 2025

https://www.fiercebiotech.com/medtech/tct-2024-jjs-abiomed-clears-pivotal-study-shrinkable-heart-pump

FIERCE BIOTECH
30 Oct 2024

https://www.fiercebiotech.com/medtech/acc-jjs-abiomed-pump-reduces-deaths-after-widowmaker-heart-attacks

Conor Hale FIERCE BIOTECH
09 Apr 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-classifies-recall-abiomeds-blood-pumps-most-serious-2024-03-21/#:~:text=Abiomed's%20so%2Dcalled%20recall%20of,during%20operations%2C%20the%20FDA%20said.

REUTERS
22 Mar 2024

https://www.fiercebiotech.com/medtech/jjs-abiomed-receives-class-i-recall-label-over-potential-impella-collisions-tavr-implants

Conor Hale FIERCE BIOTECH
18 Jul 2023

https://www.abiomed.com/about-us/news-and-media/press-releases/johnson-and-johnson-completes-acquisition-of-abiomed

ABIOMED
23 Dec 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty